EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.8 | propranolol | competitive, reaction with lidocaine or bupivacaine | Sus scrofa |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.14.13.8 | 0.143 | - |
lidocaine | pH 8.0, 25°C | Sus scrofa | |
1.14.13.8 | 0.21 | - |
propranolol | pH 8.0, 25°C | Sus scrofa | |
1.14.13.8 | 0.408 | - |
bupivacaine | pH 8.0, 25°C | Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.13.8 | Sus scrofa | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.14.13.8 | - |
Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.14.13.8 | liver | - |
Sus scrofa | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.14.13.8 | 0.122 | - |
activity with bupivacaine | Sus scrofa |
1.14.13.8 | 0.141 | - |
activity with propranolol | Sus scrofa |
1.14.13.8 | 0.176 | - |
activity with lidocaine | Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.13.8 | bupivacaine + NADPH + O2 | - |
Sus scrofa | bupivacaine-oxide + NADP+ | - |
? | |
1.14.13.8 | lidocaine + NADPH + O2 | - |
Sus scrofa | lidocaine-oxide + NADP+ | - |
? | |
1.14.13.8 | propranolol + NADPH + O2 | - |
Sus scrofa | propranolol-hydroxylamine + NADP+ | - |
? |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.14.13.8 | FAD | - |
Sus scrofa | |
1.14.13.8 | NADPH | - |
Sus scrofa |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.14.13.8 | 0.2 | - |
propranolol | pH 8.0, 25°C, inhibition of reaction with lidocaine | Sus scrofa |